Global Dental Bone Graft Substitute
Market stood at USD735.48 million in 2021 and is further anticipated to grow at
a CAGR of 7.00%, during the forecast period owing to rising geriatric
population. Additionally, growing popularity of medical and dental tourism
especially in the developing countries especially in the Asia Pacific region is
expected to create lucrative opportunities for the market growth in the coming
years. Due to the low
cost of dental treatment and the availability of surgeons, the number of
overseas patients seeking these operations is expected to increase.
Furthermore, increased focus of key
players on research and development in bone grafts and substitutes, as well as
an increase in demand for orthopedic operations among the geriatric population,
are projected to provide market players with lucrative prospects in the future.
Rising
Inclination towards Cosmetic Dentistry
Customer’s
growing desire for dental bone graft substitutes, as well as a growing
preference for cosmetic dentistry, are two important growth drivers for the
industry. Major global population is unhappy with the appearance of their
teeth. The growing number of cosmetic dental surgeries across the globe has
significantly increased the demand for dental bone graft substitutes.
Increase in Geriatric
Population
The
expanding target population is a major factor in the market for dental bone
transplants and alternatives. According to the Population Division of the
Department of Economic and Social Affairs, the global share of individuals aged
60 and more increased from 9.2% in 1990 to 11.7 percent in 2013 and is
anticipated to rise to 21.1 percent by 2050. The demand for dental grafting is
increasing due to an increased frequency of periodontal disease, root caries,
and edentulous patients, as well as the senior population.
Increase
in Dental Tourism
Patients
now have a better alternative to bone transplants thanks to advances in Dental
bone graft substitutes, but their expensive cost has hindered its use among
price-conscious customers. In this product category, developed regions such as
North America and Europe have a strong presence of innovative product makers.
However, the costs of products as well as the expenses of procedures in
hospitals in these regions are greater than in growing nations such as India,
China, and Brazil, which may prove to be the key driving force for market
expansion.

DOWNLOAD FREE SAMPLE REPORT
Market Segmentation
The Global Dental Bone Graft Substitute
Market is segmented based on Type, Material, Mechanism, Product
Type, Application, End User, and Region’s distribution. Based on type of Material,
the market can be split into Allograft,
Xenograft, Autograft, Synthetic Bone Graft, Others. Based on Material, the
market can be divided into Human
Cell Source, Collagen, Animal Source, Others, Others. Based on Mechanism, the
market is divided into Osteoconduction, Osteoinduction, Osteopromotion,
Osteogenesis. Based on Product type, the market is divided into Bio OSS,
Grafton and Osteograf. In terms of Application, the market can be categorized
into Socket Preservation, Ridge Augmentation,
Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift. Based
on End User, the market is split into Hospitals & Clinics, Dental
Laboratories, Others. Regionally, North America dominated the market in 2021
among Europe, Asia Pacific, South America and Middle East & Africa region.
United States is the biggest market for dental bone graft substitutes and stood
at USD207.54 million in 2021 on account of widespread use and adoption of
dental bone graft substitutes in various restorative and cosmetic surgeries.
Company Profiles
Institut Straumann AG, Medtronic Plc.,
Zimmer Biomet Holdings, Inc., Envista Holdings Corporation (Danaher
Corporation), DENTSPLY Sirona, Inc., Johnson & Johnson, Stryker Corporation,
Halma Plc. (NovaBone), Geistlich Pharma AG, RTI Surgical, are among the major
market players in the global platform that lead the market growth of the global
Dental Bone Graft Substitute market.
Attribute
|
Details
|
Market size value in 2021
|
USD 735.48 Million
|
Revenue Forecast in 2027
|
USD 1096.34
Million
|
United States Market size value in 2021
|
USD 207.54 Million
|
Growth Rate
|
7.00%
|
Base Year
|
2021
|
Historical Years
|
2017 –
2027
|
Estimated Year
|
2022
|
Forecast Period
|
2021
– 2027
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
Report Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments Covered
|
·
Type
·
Material
·
Mechanism
·
Product
·
Application
·
End User
|
Regional Scope
|
North
America; Europe; Asia Pacific; South America; Middle East & Africa
|
Country Scope
|
United States; Canada; Mexico; Germany; Italy; France; Poland;
Spain; United Kingdom; China; India; Japan; South Korea; Thailand; Australia;
Malaysia; Vietnam; Brazil; Argentina; Colombia; Turkey; Egypt; Saudi Arabia;
UAE; South Africa
|
Key Companies Profiled
|
Institut
Straumann AG, Medtronic Plc., Zimmer Biomet Holdings, Inc., Envista Holdings
Corporation (Danaher Corporation), DENTSPLY Sirona, Inc., Johnson &
Johnson, Stryker Corporation, Halma Plc.(NovaBone), Geistlich Pharma AG, RTI
Surgical.
|
Customization Scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
Pricing and Purchase Options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
Delivery Format
|
PDF and
Excel through Email (We can also provide the editable version of the report
in PPT/pdf format on special request)
|
Report Scope: